Vicore starts dosing of first COVID-19 patients in the global phase 3 trial ATTRACT-3 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
STOCKHOLM, Aug. 26, 2021 /PRNewswire/ Important events during the second quarter In May, Vicore1 announced that it had entered into a collaboration agreement with Alex Therapeutics
STOCKHOLM, Aug. 26, 2021 /PRNewswire/ Important events during the second quarter In May, Vicore1 announced that it had entered into a collaboration agreement with Alex Therapeutics
Vicore announces participation in investor meetings during June 2021 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Vicore Pharma Holding AB (publ) ("Vicore"), a rare disease pharmaceutical company developing innovative medicines for fibrotic lung disorders.